Literature DB >> 17056157

LPA-mediated demyelination in ex vivo culture of dorsal root.

Ryousuke Fujita1, Norikazu Kiguchi, Hiroshi Ueda.   

Abstract

Lysophosphatidic acid (LPA) causes neuropathic pain with demyelination in sensory fibers. In dorsal root (DR) ex vivo culture, the addition of 0.1 microM LPA caused a characteristic demyelination at 24h in scanning and transmission electron microscopy analyses. Moreover, direct contact between C-fibers due to loss of partition by Schwann cell in Remak bundles was observed. LPA-induced demyelination of DR was concentration-dependent in the range between 0.01 and 1M, and was abolished by BoNT/C3 and Y-27632, a RhoA and Rho kinase inhibitor, respectively. The demyelination was equivalent between the preparations with and without dorsal root ganglion. LPA also caused a down-regulation of myelin proteins, such as myelin basic protein (MBP) and myelin protein zero (MPZ) to approximately 70% of control. All these findings suggest that the demyelination observed in the neuropathic pain due to nerve injury occurs through a direct action of LPA on Schwann cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056157     DOI: 10.1016/j.neuint.2006.09.003

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  22 in total

Review 1.  Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

Authors:  Mu-En Lin; Deron R Herr; Jerold Chun
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-04       Impact factor: 3.072

2.  Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes.

Authors:  Yona Goldshmit; Rosalia Matteo; Tamar Sztal; Felix Ellett; Frisca Frisca; Kelli Moreno; Duncan Crombie; Graham J Lieschke; Peter D Currie; Roger A Sabbadini; Alice Pébay
Journal:  Am J Pathol       Date:  2012-07-20       Impact factor: 4.307

Review 3.  Lysophospholipid receptor nomenclature review: IUPHAR Review 8.

Authors:  Yasuyuki Kihara; Michael Maceyka; Sarah Spiegel; Jerold Chun
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

4.  Modulation of LPA receptor expression in the human brain following neurotrauma.

Authors:  Tony Frugier; Duncan Crombie; Alison Conquest; Frisca Tjhong; Caroline Taylor; Tejal Kulkarni; Catriona McLean; Alice Pébay
Journal:  Cell Mol Neurobiol       Date:  2011-01-15       Impact factor: 5.046

5.  Calpain-mediated down-regulation of myelin-associated glycoprotein in lysophosphatidic acid-induced neuropathic pain.

Authors:  Weijiao Xie; Hitoshi Uchida; Jun Nagai; Mutsumi Ueda; Jerold Chun; Hiroshi Ueda
Journal:  J Neurochem       Date:  2010-05       Impact factor: 5.372

6.  Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain.

Authors:  J Vaigunda Ragavendran; André Laferrière; Wen Hua Xiao; Gary J Bennett; Satyanarayana S V Padi; Ji Zhang; Terence J Coderre
Journal:  J Pain       Date:  2013-01       Impact factor: 5.820

7.  Schwann cell LRP1 regulates remak bundle ultrastructure and axonal interactions to prevent neuropathic pain.

Authors:  Sumihisa Orita; Kenneth Henry; Elisabetta Mantuano; Kazuyo Yamauchi; Alice De Corato; Tetsuhiro Ishikawa; M Laura Feltri; Lawrence Wrabetz; Alban Gaultier; Melanie Pollack; Mark Ellisman; Kazuhisa Takahashi; Steven L Gonias; W Marie Campana
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

Review 8.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

9.  Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine.

Authors:  Jun Nagai; Hitoshi Uchida; Yosuke Matsushita; Ryo Yano; Mutsumi Ueda; Masami Niwa; Junken Aoki; Jerold Chun; Hiroshi Ueda
Journal:  Mol Pain       Date:  2010-11-09       Impact factor: 3.395

10.  Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.

Authors:  Lin Ma; Hitoshi Uchida; Jun Nagai; Makoto Inoue; Jerold Chun; Junken Aoki; Hiroshi Ueda
Journal:  Mol Pain       Date:  2009-11-13       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.